FROM THE EDITOR-IN-CHIEF
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Forward Look
Targeted Chemotherapy | Drug Combo Targets Polyp Growth | FDA Acts to Curb Nicotine Use | Cloning Cancer | Putting Age in the Cancer Picture | Back to School | What’s Next?
POLICY MATTERS
The number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
YOUR CANCER GUIDE
A second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
Recognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
Survivor Profile
Janet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
Healthy Habits
Go Fish | Against the Clock
Q&A
Palliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients’ values guide end-of-life decisions.
by Marci A. Landsmann
Sound Advice
A patient support expert offers guidance on how to respond to news of a friend’s cancer diagnosis.
Get Involved
Help with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR